Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nike Inc (NKE) vs Tilray Brands Inc (TLRY) Price & Performance

Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Nike Inc vs Tilray Brands Inc — how do they compare? Nike Inc trades at $40.58 (market cap $61.30B), while Tilray Brands Inc trades at $4.66 (market cap $649.42M). The key difference: Nike Inc is far larger — about 94.4× Tilray Brands Inc's market cap, and Nike Inc pays a 3.97% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

NKETLRY
Market Cap
$61.30B$649.42M
Volume
8,887,180
Sector
Consumer CyclicalHealth
52-Week High
$79.17$21.00
52-Week Low
$40.75$3.88
Enterprise Value
$63.30B$816.55M
Dividend Yield
3.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nike Inc

Nike (NKE) trades at $42.11, up 0.98% on the day, showing resilience amid a challenging period. The stock faces bearish technical signals but maintains strong profitability metrics including 42.91% gross margin and 22.14% ROE. Recent earnings have consistently beaten expectations, with Q1 2026 EPS of $0.72 significantly exceeding the $0.11 forecast. However, revenue declined to $46.31B in 2025 from $51.4B in 2024, reflecting ongoing business headwinds.

Nike's investment case balances strong brand value and consistent earnings beats against revenue pressures and competitive challenges. The consensus price target of $50.45 suggests 20% upside potential, though technical indicators remain bearish. Key risks include China market weakness and inventory management issues, while opportunities lie in digital transformation and product innovation driving future growth.

Tilray Brands Inc

TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.

Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.

Returns comparison

Trailing returns across standard periods

About Nike Inc

NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.

Read more on NKE

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY